ARCT vs COST · rev $152.3M vs P/E 55, rev $275.24B
Arcturus Therapeutics Holdings Inc (ARCT) versus Costco Wholesale Corp (COST) — a side-by-side from cached financials, not a winner call.
Arcturus Therapeutics Holdings Inc (ARCT) is a biotechnology company listed on US.
Costco Wholesale Corp (COST) is a discount stores company listed on US. It is led by Ron Vachris.
Latest reported ARCT revenue for 2024-12-31 was $152.3M. Net income was -$80.9M. Revenue was down 8.7% from 2023-12-31 to 2024-12-31. ARCT currently screens at market cap $369.4M.
Latest reported COST revenue for 2025-08-31 was $275.24B. Net income was $8.10B. COST currently screens at market cap $430.32B and trailing P/E 54.9.
ARCT currently screens at market cap $369.4M. COST currently screens at market cap $430.32B and trailing P/E 54.9.
Not investment advice. Open the ARCT and COST stock pages for the full models.
Not investment advice.